Determinants | Category | Total | Negative Non-SN | Positive Non-SN | ||
---|---|---|---|---|---|---|
N | % | N | % | |||
Screening | No | 309 | 197 | 50.4 | 112 | 53.1 |
Yes | 278 | 190 | 48.6 | 88 | 41.7 | |
Unknown | 15 | 4 | 1.0 | 11 | 5.2 | |
Age | ≤50 | 151 | 103 | 26.3 | 48 | 22.7 |
51–74 | 370 | 239 | 61.1 | 131 | 62.1 | |
≥75 | 81 | 49 | 12.5 | 32 | 15.2 | |
Menopause Status | Pre | 153 | 104 | 26.6 | 49 | 23.2 |
Post < 5 ys | 57 | 42 | 10.7 | 15 | 7.1 | |
Post ≥5 ys | 370 | 231 | 59.1 | 139 | 65.9 | |
Unknown | 22 | 14 | 3.6 | 8 | 3.8 | |
Tumour size | T1 | 331 | 220 | 56.3 | 111 | 52.6 |
T2 | 193 | 120 | 30.7 | 73 | 34.6 | |
T3 & T4 | 10 | 6 | 1.5 | 4 | 1.9 | |
Unknown | 68 | 45 | 11.5 | 23 | 10.9 | |
Tumour type | Ductal | 490 | 331 | 84.7 | 159 | 75.4 |
D & L | 14 | 5 | 1.3 | 9 | 4.3 | |
Lobular | 79 | 41 | 10.5 | 38 | 18.0 | |
Other | 19 | 14 | 3.6 | 5 | 2.4 | |
Histological grade | I | 118 | 82 | 21.0 | 36 | 17.1 |
II | 272 | 176 | 45.0 | 96 | 45.5 | |
III | 210 | 132 | 33.8 | 78 | 37.0 | |
Unknown | 2 | 1 | 0.3 | 1 | 0.5 | |
Estrogen receptor | Positive | 545 | 358 | 91.6 | 187 | 88.6 |
Negative | 56 | 33 | 8.4 | 23 | 10.9 | |
Unknown | 1 | 0 | 0.0 | 1 | 0.5 | |
Progesterone receptor | Positive | 478 | 319 | 81.6 | 159 | 75.4 |
Negative | 122 | 72 | 18.4 | 50 | 23.7 | |
Unknown | 2 | 0 | 0.0 | 2 | 0.9 | |
HER2 status | Negative | 383 | 248 | 63.4 | 135 | 64.0 |
Positive | 61 | 33 | 8.4 | 28 | 13.3 | |
Unknown | 158 | 110 | 28.1 | 48 | 22.7 | |
Multifocality | No | 355 | 247 | 63.2 | 108 | 51.2 |
Yes | 129 | 63 | 16.1 | 66 | 31.3 | |
Unknown | 118 | 81 | 20.7 | 37 | 17.5 | |
Vascular invasion | No | 241 | 166 | 42.5 | 75 | 35.5 |
Yes | 91 | 60 | 15.3 | 31 | 14.7 | |
Unknown | 270 | 165 | 42.2 | 105 | 49.8 |